WHO Drug Information Vol. 16, No. 1, 2002
(2002; 116 pages)

Índice de contenido

	Preface
	Vaccines and Biomedicines
		International reference materials for Creutzfeldt-Jakob disease
		WHO position on rabies vaccine
	Safety Information
		WHO international drug monitoring: cerivastatin and gemfibrozil
		International Conference on Harmonization (ICH): pharmacovigilance activities
		The COX-2 inhibitors
		Amiodarone and pulmonary toxicity
		Alendronate: link with pancreatitis?
		Endocrinotoxicity induced by Coriandrum sativa: a case report
		Haemolysis after consumption of Viola tricolor
		Lipodystrophy syndrome under-reported
	Current Topics
		Progress in pharmacogenetics and pharmacogenomics*
		Internet sales and reimbursement by insurance companies
		Nevirapine: comments on HIVNET 012 from the manufacturer
		Review of HIVNET 012
		Mother to child transmission of HIV: WHO statement
	Regulatory and Safety Action
		Enoxaparin sodium injection: new safety warnings
		Ziprasidone hydrochloride: labelling clarifications
		Kava kava products and potential liver injury
		Kava kava: investigations into liver injury
		Rofecoxib interaction with warfarin
		Zolpidem and neurological reactions
		Paroxetine: severe withdrawal symptoms
		Hua Fo: unknown substance
		Sibutramine safety review
		Cyproterone with ethinylestradiol: risk of venous thromboembolism
		Alfa interferons: labelling change
		Nefazodone: rare cases of liver failure
		Acarbose, zafirlukast and vincristine: revised precautions
		Clozapine and myocarditis
		Methotrexate: interactions
		Stavudine: neuromuscular weakness
		Recommended influenza virus vaccine composition
		Sodium phosphate oral solution: electrolyte balance disturbance
	Quality Assurance Issues
		Pilot procurement project for quality and sourcing (pre-qualification) of HIV/AIDS drugs
		Current status of the project
		List of pre-qualified products - 20 March 2002
	Recent Publications and Sources of Information
		WHO guidelines on stability testing
		WHO Model Formulary now available
		Direct to consumer advertising
		The information gap: new resource for developing countries
	Proposed International Nonproprietary Names: List 86
	Recommended International Nonproprietary Names (Rec. INN): List 47
	Selected WHO publications of related interest

WHO Drug Information Vol. 16, No. 1, 2002

WORLD HEALTH ORGANIZATION • GENEVA

PROPOSED INN LIST 86

RECOMMENDED INN LIST 47
INTERNATIONAL NONPROPRIETARY NAMES
FOR PHARMACEUTICAL SUBSTANCES

Printed in Malta
2002/14565 - Interprint - 5300